Clinical Trial: Lipitor® (atorvastatin, a cholesterol-lowering drug) and Rebif® (interferon beta-1a) - National Multiple Sclerosis Society

Skip to navigation Skip to content

Clinical Trial: Lipitor® (atorvastatin, a cholesterol-lowering drug) and Rebif® (interferon beta-1a)

Share

Details
Type of MS: RRMS
Treatment mode of action: To affect immune function
Number of Subjects: 30
Medication: Lipitor, Rebif
Location: NC
Contact Information
Cynthia Kenan
(919) 843-7641

Funding:

Serono/Pfizer

Description

Randomized, double-blinded, placebo-controlled study to test safety and effectiveness of a combination of Lipitor and Rebif.

Share